Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Orion Corporation: Managers’ transactions – Liisa Hurme | ||||||
By: GlobeNewswire - 23 Jul 2021 | Back to overview list |
|||||
ORION CORPORATION MANAGERS’ TRANSACTIONS 23 JULY 2021 at 3:00 p.m. EEST Orion Corporation: Managers’ transactions – Liisa Hurme Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596/2014, regarding transactions with shares and linked securities in Orion Corporation made by managers and their closely associated persons. Orion Oyj - Managers' Transactions Person subject to the notification requirement Notification type: INITIAL NOTIFICATION Transaction date: Transaction details Aggregated transactions Orion Corporation
Publisher: Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki. |
||||||
|
||||||
Copyright 2021 GlobeNewswire | Back to overview list |